What's In Store For You? 

With advanced therapies reshaping the future of medicine, pharma leaders are under pressure to integrate cutting-edge science while navigating regulatory and manufacturing complexity. Advanced Therapies Europe brings you face-to-face with the biotech pioneers and solution providers driving change.

Join your peers to accelerate partnerships, de-risk pipelines, and explore next-gen CGT innovations.

  • Discover emerging technologies and platforms from agile innovators

  • Forge partnerships that support long-term strategic growth

  • Gain insight into the future of manufacturing, commercialisation, and regulation

Apply to attend

Key themes to discover...

  • Commercialisation Strategies for European Market Success: Gain insights from leading pharma execs who’ve brought ATMPs to market in Europe. Learn what’s working (and what isn’t) when scaling therapies and navigating fragmented reimbursement systems.
  • Smarter Market Access: Understand how real-world data and adaptive pricing models are being used to secure sustainable reimbursement to help make more informed go/no-go decisions.

  • Regulatory Alignment Across Europe: Join closed discussions with regulators and peers to shape unified regulatory approaches across Europe to enable faster, clearer market pathways for new therapies.
  • Tech Transfer & Scale-Up: See how other pharma companies are tackling batch variability, raw material sourcing and scale-up challenges to save your teams' time and reduce risk in tech transfer.

Your Personalised Itinerary

09:55
  1. Plenary

    Deep dive into the regulatory framework that governs CGT across major rejoins, focusing on recent updates, new legislation and how companies can navigate the changing landscape.

10:25
  1. Plenary
    A conversation with key patient advocates and organisations to highlight the importance of patient engagement, access, and ensuring therapies meet real-world needs in CGT.
11:30
    • R&D, clinical innovation & translation
    Theatre 1
    • Cutting edge developments in CRISPR, gene editing and cell engineering
    • The next wave of in vivo and ex vivo gene therapies
    • What breakthroughs are expected to reshape the industry?
    • Manufacturing, scale up & commercial strategy
    Theatre 2
    • As the pressure mounts to deliver advanced therapies faster, cheaper, and closer to the patient, decentralised manufacturing is stepping into the spotlight. But does breaking away from centralised models really deliver on cost? 

    • This panel dives into the economic realities behind the decentralisation trend. Are localised manufacturing hubs the answer to cutting costs, or do they introduce new layers of complexity and hidden spend? From infrastructure investments to regulatory headaches, we’ll separate financial fact from fiction and explore whether decentralisation is a bold leap forward or an expensive detour. 

12:25
    • R&D, clinical innovation & translation
    Theatre 1
    • Manufacturing, scale up & commercial strategy
    Theatre 2
12:50
    • R&D, clinical innovation & translation
    Theatre 1
    • Scientific advances and key breakthroughs.
    • Safety, efficacy, and regulatory challenges.
    • Investment trends and commercialisation potential.
14:30
    • Manufacturing, scale up & commercial strategy
    Theatre 2
    • Transitioning from academic proof of concept to market-ready product 

    • Why biotech teams must integrate CMC, regulatory and pharmacology early 

    • Avoiding pitfalls of overselling and overpromising 

15:05
    • R&D, clinical innovation & translation
    Theatre 1
    • Why characterisation and analytics remain a major hurdle. 

    • Collaborative approaches to tackling technical challenges 

    • Best practices and emerging solutions. 

    • Manufacturing, scale up & commercial strategy
    Theatre 2
    Discuss the key challenges in patient-centric manufacturing, focusing on ensuring timely delivery of therapies, managing logistics, and addressing issues related to personalised treatments, from patient selection to product delivery. 
15:40
    • Manufacturing, scale up & commercial strategy
    Theatre 2
16:00
    • Manufacturing, scale up & commercial strategy
    Theatre 2
11:30
    • R&D, clinical innovation & translation
    Theatre 1
    • Manufacturing, scale up & commercial strategy
    Theatre 2
14:00
    • R&D, clinical innovation & translation
    Theatre 1
    • Manufacturing, scale up & commercial strategy
    Theatre 2
14:20
    • R&D, clinical innovation & translation
    Theatre 1
15:15
  1. Plenary

    AI is everywhere, but in CGT, real deployment remains limited. This session goes beyond the buzz to explore the tangible opportunities, early wins, and critical barriers to broader adoption. 

    We’ll look at where AI is beginning to make a difference and what’s still needed to move from isolated pilots to real impact. What kind of data, infrastructure, and cross-functional collaboration will unlock AI’s full potential in CGT? 

16:00
  1. Plenary
    As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed. 

Discover Advanced Therapies Week as a pharmaceutical company

Explore how Advanced Therapies Week empowers biotechs to accelerate their commercialization journey. From engaging with investors at our exclusive Investor Pre-Day to building valuable partnerships with industry leaders, every moment is designed to drive your success. Dive into the agenda, connect with peers, and meet solution providers ready to support your growth.

Content Packed Agenda

Gain insights, meet investors, and accelerate your path to commercialization.

State of the Art Networking

Discover promising companies, network with peers, and explore new opportunities.

Source Cutting-Edge Innovation

Discover high-potential biotech partners aligned with your pipeline and external innovation goals.

De-risk Through Strategic Collaboration

Hear from peers on building value-driven partnerships that balance risk and reward across the CGT lifecycle.

Who Might You Find On the Show Floor?

Sample Attendee List Current Exhibitor List

500+
Attendees
40+
Companies
150+
Speakers
170+
Therapeutic Developers

 

  • "What an incredible few days at the ATE conference by Phacilitate! Grateful for the power of my network and the opportunity to meet so many familiar faces while growing it further.”
    Head of Business Development: Cell Therapy and Laboratory Services | Cell and Gene Therapy
  • “Impactful moments and connections.”
    Director Global Cell and Gene Therapies Portfolio Management | EMBA | Deep Tech
  • “Already having fantastic conversations here at ATE24 in Lisbon.”
    Experienced Leader in Cell and Gene Therapy Business and Commercial Strategy

Our Sponsors